MassachusettsH 2372194th General Court (2025-2026)House

An Act relative to collaborative drug therapy management optimization

Sponsored By: Christine P. Barber (Democratic)

In Committee

Public HealthHealth Care FinancingHouse Ways and Means

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Christine P. Barber

    Democratic • House

Cosponsors

  • Patrick Joseph Kearney

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 24 • No: 0

committee vote 4/9/2026

Committee Favorable: Favorable Report

Yes: 13 • No: 0

committee vote 7/7/2025

Committee Favorable: Should H2372, An Act relative to collaborative drug therapy management optimization be reported out with Recommendation: Ought to pass, report to the House?

Yes: 11 • No: 0

Actions Timeline

  1. Committee recommended bill ought to pass and referred to the committee on House Ways and Means

    4/15/2026House
  2. Reporting date extended to Monday, June 15, 2026

    3/19/2026House
  3. Reporting date extended to Wednesday, March 18, 2026

    12/8/2025House
  4. Reported favorably by committee and referred to the committee on Health Care Financing

    7/24/2025House
  5. Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1

    6/6/2025legislature
  6. Senate concurred

    2/27/2025Senate
  7. Referred to the committee on Public Health

    2/27/2025House

Bill Text

Related Bills

Back to State Legislation